Market Forecast By Product Type (Quantitative PCR, Digital PCR), By Application (Clinical Applications, Research Applications, Pathogen Testing, Oncology Testing, Blood Screening, Others), By End-user (Hospitals & Diagnostic Centers, Research Laboratories & Academic Institutes, Pharmaceutical & Biotechnology Companies, Clinical Research Organizations, Forensic Laboratories) And Competitive Landscape
Product Code: ETC9618147 | Publication Date: Sep 2024 | Updated Date: Jan 2025 | Product Type: Market Research Report | |
Publisher: 6Wresearch | No. of Pages: 64 | No. of Figures: 17 | No. of Tables: 3 | |
Taiwan Digital PCR & Quantitative PCR Market Report thoroughly covers the market By Technology, By Application and By End-User. Taiwan Digital PCR & Quantitative PCR Market Outlook report provides an unbiased and detailed analysis of the ongoing Taiwan Digital PCR & Quantitative PCR Market trends, opportunities/high growth areas, and market drivers. This would help stakeholders devise and align their market strategies according to the current and future market dynamics.
Taiwan Digital PCR & Quantitative PCR Market is set for substantial growth, driven by the rising incidence of infectious diseases and the expansion of the Healthcare & Biomedical sector. The Taiwan Annual Health Report revealed an increase in rare diseases from 235 in 2021 to 243 in 2023, emphasizing the demand for advanced diagnostics. Furthermore, National Health Expenditure as a percentage of GDP grew from 7.3% in 2021 to 7.5% in 2022. Significant investments by global companies, including Microsoft’s US$34 million commitment to AI centers, alongside collaborations with Amazon, IBM, and Yahoo, along with government incentives, would further accelerate market expansion.
According to 6Wresearch, the Taiwan Digital PCR & Quantitative PCR Market size is projected to grow at a CAGR of 4.5% during 2024–2030. Taiwan’s Digital PCR & Quantitative PCR market is set for strong growth, driven by the expansion of biomedical sector which is expected to reach $32.2 billion in 2025 from $25.8 billion in 2022. This expansion is largely driven by policies such as precision health initiatives and tax incentives for companies involved in new drug research and biotech development, which would remain in place until 2031.
Additionally, Taiwan’s aging population, which now accounts for over 14% of the total population, has led to the adaptation of policies and regulations to support medical trials and innovative service models. Furthermore, Taiwan's healthcare system is well-positioned to continue expanding, supported by its high-quality medical services, well-trained personnel, and advanced equipment. As a top 10 medical tourism destination, Taiwan is rapidly emerging as a hub for cutting-edge medical technologies. This expansion in Taiwan’s healthcare sector is expected to drive the demand for diagnostic tools such as dPCR/qPCR (digital PCR/quantitative PCR).
By 2030, digital PCR (dPCR) technology is expected to hold a significant share of Taiwan's dPCR & qPCR market, driven by its role in advancing precision diagnostics, enabling more accurate and sensitive molecular analysis. Government initiatives supporting biomedical innovation, along with the growing demand for high-quality diagnostics, would further accelerate the adoption of dPCR technologies in Taiwan’s healthcare and research sectors.
By 2030, Oncology Testing is expected to hold a significant share in Taiwan’s digital PCR& quantitative PCR market, driven by its role in advancing cancer diagnostics and personalized treatments. The increasing prevalence of cancer, along with government initiatives like the National Cancer Control Program, which supports research and early detection technologies, would further enhance the growth of oncology testing in Taiwan’s molecular diagnostics sector.
By 2030, Pharmaceutical & Biotechnology Companies would drive significant growth in Taiwan's dPCR/qPCR market due to the rising demand for precise diagnostics, personalized medicine, and advancements in drug development. The accuracy and sensitivity of dPCR/qPCR technologies enable more efficient clinical trials and disease detection. Government initiatives like the "Taiwan Biotech 2030" plan, which supports biotech innovation through funding and infrastructure, would further fuel this growth. Additionally, collaborations with global firms would enhance expertise and technology transfer, accelerating the adoption of dPCR/qPCR solutions and solidifying Taiwan's position as a leader in biotechnology by 2030.
The report provides a detailed analysis of the following market segments:
1. Executive Summary |
2. Introduction |
2.1 Key Highlights of the Report |
2.2 Report Description |
2.3 Market Scope & Segmentation |
2.4 Methodology |
2.5 Assumptions |
3. Taiwan Digital PCR & Quantitative PCR Market Overview |
3.1 Taiwan Digital PCR & Quantitative PCR Market Demand Revenues, 2020 – 2030F |
3.2 Taiwan Digital PCR & Quantitative PCR Market Industry Life Cycle |
3.3 Taiwan Digital PCR & Quantitative PCR Market Porter’s Five Forces |
4. Taiwan Digital PCR & Quantitative PCR Market Dynamics |
4.1 Impact Analysis |
4.2 Market Drivers |
4.3 Market Restraints |
5. Taiwan Digital PCR & Quantitative PCR Market Evolution & Trends |
6. Taiwan Digital PCR & Quantitative PCR Market Overview, By Technology |
6.1 Taiwan Digital PCR & Quantitative PCR Market Revenue Share and Revenues, By Technology, 2020-2030F |
6.1.1 Taiwan Digital PCR & Quantitative PCR Market Revenues, By Digital PCR, 2020-2030F |
6.1.2 Taiwan Digital PCR & Quantitative PCR Market Revenues, By Quantitative PCR, 2020-2030F |
7. Taiwan Digital PCR & Quantitative PCR Market Overview, By Application |
7.1 Taiwan Digital PCR & Quantitative PCR Market Revenue Share and Revenues, By Application, 2020-2030F |
7.1.1 Taiwan Digital PCR & Quantitative PCR Market Revenues, By Clinical Application, 2020-2030F |
7.1.2 Taiwan Digital PCR & Quantitative PCR Market Revenues, By Research Application, 2020-2030F |
7.1.3 Taiwan Digital PCR & Quantitative PCR Market Revenues, By Pathogens Testing, 2020-2030F |
7.1.4 Taiwan Digital PCR & Quantitative PCR Market Revenues, By Oncology Testing, 2020-2030F |
7.1.5 Taiwan Digital PCR & Quantitative PCR Market Revenues, By Blood Screening, 2020-2030F |
7.1.6 Taiwan Digital PCR & Quantitative PCR Market Revenues, By Others, 2020-2030F |
8. Taiwan Digital PCR & Quantitative PCR Market Overview, By End-User |
8.1 Taiwan Digital PCR & Quantitative PCR Market Revenue Share and Revenues, By End User, 2020-2030F |
8.1.1 Taiwan Digital PCR & Quantitative PCR Market Revenues, By Hospitals & Diagnostic Centers, 2020-2030F |
8.1.2 Taiwan Digital PCR & Quantitative PCR Market Revenues, By Research Laboratories & Academic Institutes, 2020-2030F |
8.1.3 Taiwan Digital PCR & Quantitative PCR Market Revenues, By Pharmaceutical & Biotechnology Companies, 2020-2030F |
8.1.4 Taiwan Digital PCR & Quantitative PCR Market Revenues, By Clinical Research Organizations, 2020-2030F |
8.1.5 Taiwan Digital PCR & Quantitative PCR Market Revenues, By Forensic Laboratories, 2020-2030F |
9. Taiwan Digital PCR & Quantitative PCR Market Key Performance Indicators |
10. Taiwan Digital PCR & Quantitative PCR Market Opportunity Assessment |
10.1 Taiwan Digital PCR & Quantitative PCR Market Opportunity Assessment, By Technology, 2030F |
10.2 Taiwan Digital PCR & Quantitative PCR Market Opportunity Assessment, By Application, 2030F |
10.2 Taiwan Digital PCR & Quantitative PCR Market Opportunity Assessment, By End-User, 2030F |
11. Taiwan Digital PCR & Quantitative PCR Market Competitive Landscape |
11.1 Taiwan Digital PCR & Quantitative PCR Market Share, By Companies, 2023 |
11.3 Taiwan Digital PCR & Quantitative PCR Market Competitive Benchmarking, By Operating Parameters |
12. Company Profiles |
12.1 Bio-Rad Laboratories Inc. |
12.2 Agilent Technologies |
12.3 F. Hoffmann-La Roche Ltd |
12.4 Takara Bio Inc |
12.5 Thermo Fisher Scientific Inc. |
12.6 QIAGEN |
12.7 Promega Corporation |
12.8 Eppendorf SE |
12.9 Merck KGaA |
12.10 Stilla |
13. Key Strategic Recommendations |
14. Disclaimer |
List of Figures |
1. Taiwan Digital PCR & Quantitative PCR Market Revenues, 2020-2030F ($ Million) |
2. Taiwan Rare Diseases Overview 2021-2023 |
3. Emergency Visits in Taiwan for Enterovirus Disease in Taiwan, August-December 2024 (Thousands) |
4. Confirmed Cases of Severe Complicated Influenza in Taiwan April-August 2024 |
5. Taiwan Digital PCR & Quantitative PCR Market Revenue Share, By Technology, 2023 & 2030F |
6. Taiwan Digital PCR & Quantitative PCR Market Revenue Share, By Application, 2023 & 2030F |
7. Taiwan Digital PCR & Quantitative PCR Market Revenue Share, By End-User, 2023 & 2030F |
8. Taiwan’s Biomedical Industry Latest Development |
9. Taiwan’s Biotechnology Industry 2018-2022 USD Billion |
10. Taiwan’s Biomedical Industry 2021-2025F USD Billion |
11. Taiwan’s National Health Expenditure as a Percentage of GDP 2018-2022 |
12. Taiwan AI Healthcare Market 2023-2030 in Million |
13. Taiwan Digital PCR & Quantitative PCR Market Opportunity Assessment, By Technology, 2030F |
14. Taiwan Digital PCR & Quantitative PCR Market Opportunity Assessment, By Application, 2030F |
15. Taiwan Digital PCR & Quantitative PCR Market Opportunity Assessment, By End-User, 2030F |
16. Taiwan Digital PCR & Quantitative PCR Market Share, By Company, 2023 |
17. Taiwan Biomedical Clusters Regional Distribution, 2023 |
List of Tables |
1. Taiwan Digital PCR & Quantitative PCR Market Revenues, By Technology, 2020-2030F ($ Million) |
2. Taiwan Digital PCR & Quantitative PCR Market Revenues, By Application, 2020-2030F ($ Million) |
3. Taiwan Digital PCR & Quantitative PCR Market Revenues, By End-User, 2023-2030F ($Million) |